Opioids in Chronic Noncancer Pain: More Faces from the Crowd
BACKGROUND: The use of opioids for chronic noncancer pain (CNCP) remains very controversial. There are several randomized controlled trials, mostly in neuropathic pain, reporting efficacy and safety in the short term, but more long-term data are needed. Randomized controlled trials may be limited in...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2012/495781 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554343663927296 |
|---|---|
| author | C Peter N Watson |
| author_facet | C Peter N Watson |
| author_sort | C Peter N Watson |
| collection | DOAJ |
| description | BACKGROUND: The use of opioids for chronic noncancer pain (CNCP) remains very controversial. There are several randomized controlled trials, mostly in neuropathic pain, reporting efficacy and safety in the short term, but more long-term data are needed. Randomized controlled trials may be limited in providing data about the patients who benefit from often high-dose opioids over the long term. The present article provides details of these patients and adds to a previous case series. |
| format | Article |
| id | doaj-art-1c643621874448829f376dc6361adfc4 |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-1c643621874448829f376dc6361adfc42025-02-03T05:51:39ZengWileyPain Research and Management1203-67652012-01-0117426327510.1155/2012/495781Opioids in Chronic Noncancer Pain: More Faces from the CrowdC Peter N Watson0University of Toronto, Toronto, Ontario, CanadaBACKGROUND: The use of opioids for chronic noncancer pain (CNCP) remains very controversial. There are several randomized controlled trials, mostly in neuropathic pain, reporting efficacy and safety in the short term, but more long-term data are needed. Randomized controlled trials may be limited in providing data about the patients who benefit from often high-dose opioids over the long term. The present article provides details of these patients and adds to a previous case series.http://dx.doi.org/10.1155/2012/495781 |
| spellingShingle | C Peter N Watson Opioids in Chronic Noncancer Pain: More Faces from the Crowd Pain Research and Management |
| title | Opioids in Chronic Noncancer Pain: More Faces from the Crowd |
| title_full | Opioids in Chronic Noncancer Pain: More Faces from the Crowd |
| title_fullStr | Opioids in Chronic Noncancer Pain: More Faces from the Crowd |
| title_full_unstemmed | Opioids in Chronic Noncancer Pain: More Faces from the Crowd |
| title_short | Opioids in Chronic Noncancer Pain: More Faces from the Crowd |
| title_sort | opioids in chronic noncancer pain more faces from the crowd |
| url | http://dx.doi.org/10.1155/2012/495781 |
| work_keys_str_mv | AT cpeternwatson opioidsinchronicnoncancerpainmorefacesfromthecrowd |